Observation of the efficacy of cetirizine in treatment of chronic and acute urticaria
Jing Feng
Abstract
Jing Feng
Abstract
Objective:To evaluate the safety and efficacy of cetirizine in treatment of acute and chronic urticaria.Methods:Patients with urticaria were randomly divided to receive once daily oral 10 mg cetirizine or once daily oral 10mg Zyrtec(imported cetirizine) for 7 days (for acute urticaria) and 14 days (for chronic urticaria).Results:In cetirizine group,the effective rate was 66.7% for acute urticaria cases ( n =24) and 74.0% for chronic urticaria cases ( n =26).In the control group,the effective rate was 88.5% for acute urticaria cases( n =26) and 64.0% for chronic urticaria cases( n =25).The adverse event rate was 23.1% for active group and 19.6% for control group.There were no significant differences between groups in both the effective rate and the adverse event rate.Conclusion:Cetirizine is a safe and effective H 1 receptor antagonist for treatment of acute and chronic urticaria.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To evaluate the safety and efficacy of cetirizine in treatment of acute and chronic urticaria.Methods:Patients with urticaria were randomly divided to receive once daily oral 10 mg cetirizine or once daily oral 10mg Zyrtec(imported cetirizine) for 7 days (for acute urticaria) and 14 days (for chronic urticaria).Results:In cetirizine group,the effective rate was 66.7% for acute urticaria cases ( n =24) and 74.0% for chronic urticaria cases ( n =26).In the control group,the effective rate was 88.5% for acute urticaria cases( n =26) and 64.0% for chronic urticaria cases( n =25).The adverse event rate was 23.1% for active group and 19.6% for control group.There were no significant differences between groups in both the effective rate and the adverse event rate.Conclusion:Cetirizine is a safe and effective H 1 receptor antagonist for treatment of acute and chronic urticaria.
Key concepts: Cetirizine, Medicine, Chronic urticaria, Adverse effect, Dermatology, Anesthesia, Internal medicine